All patients (n = 165) | |
---|---|
Gender (male) | 40 (24.2%) |
Age (years, mean ± SD) | 42.5 ± 16.1 |
Previous history of TB | 13 (7.9%) |
Comorbidity | 35 (21.2%) |
Cardiovascular diseases | 25 (15.2%) |
Diabetes mellitus | 11 (6.7%) |
Chronic renal diseases | 7 (4.2%) |
Hematologic malignancy | 4 (2.4%) |
Duration of lymphadenopathy (months, mean ± SD) | 8.2 ± 29.8 |
Location of cervical lymph node | |
Bilateral | 14 (8.5%) |
Left side | 59 (35.8%) |
Right side | 92 (55.8%) |
Largest size of the lymph node (mm, mean ± SD) | 33.1 ± 24.5 |
Results of the initial diagnostic work-up | |
Compatible with TB on CT scan, n/Na | 123/143 (86.0%) |
AFB positive, n/Na | 20/96 (20.8%) |
TB culture positive, n/Na | 36/80 (45.0%) |
TB PCR positive, n/Na | 121/158 (76.6%) |
Histologic findings indicative of TB | 136/164 (82.9%) |
Paradoxical reaction during treatment | 38 (23.0%) |
CT scan after 6 months of antituberculous therapy | 157 (95.2%) |
Residual lymph nodeb | 35 (22.3%) |
Duration of antituberculous therapy (months, mean ± SD) | 7.9 ± 4.4 |